Daniel R. Getts

4.9k total citations
59 papers, 3.2k citations indexed

About

Daniel R. Getts is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Daniel R. Getts has authored 59 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 19 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Daniel R. Getts's work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (14 papers). Daniel R. Getts is often cited by papers focused on CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (14 papers). Daniel R. Getts collaborates with scholars based in United States, Australia and Germany. Daniel R. Getts's co-authors include Stephen D. Miller, Nicholas J. C. King, Rachael Terry, Meghann Teague Getts, Derrick McCarthy, Marcus Müller, Iain L. Campbell, Lonnie D. Shea, Emily M. L. Chastain and Woon Teck Yap and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Daniel R. Getts

56 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel R. Getts United States 25 1.8k 714 435 428 405 59 3.2k
Claire L. Harris United Kingdom 44 3.8k 2.1× 858 1.2× 399 0.9× 447 1.0× 321 0.8× 123 5.5k
Rachael Terry Australia 19 1.3k 0.7× 583 0.8× 380 0.9× 236 0.6× 249 0.6× 27 2.3k
Edimara S. Reis United States 32 2.9k 1.6× 836 1.2× 225 0.5× 360 0.8× 324 0.8× 61 4.5k
Dalit Strauss‐Ayali United States 22 2.0k 1.1× 672 0.9× 702 1.6× 356 0.8× 232 0.6× 31 3.6k
Sunil K. Shaw United States 30 2.2k 1.2× 1.4k 1.9× 239 0.5× 267 0.6× 271 0.7× 64 4.9k
Seema S. Ahuja United States 40 2.2k 1.2× 918 1.3× 214 0.5× 399 0.9× 575 1.4× 71 4.4k
Harris Goldstein United States 27 1.8k 1.0× 644 0.9× 391 0.9× 167 0.4× 700 1.7× 91 3.5k
Wiebke Hansen Germany 37 2.1k 1.2× 1.2k 1.7× 196 0.5× 118 0.3× 261 0.6× 99 3.9k
Béhazine Combadière France 30 2.1k 1.2× 1.0k 1.4× 699 1.6× 288 0.7× 304 0.8× 72 4.2k
An Billiau Belgium 31 1.6k 0.9× 592 0.8× 139 0.3× 284 0.7× 185 0.5× 82 3.1k

Countries citing papers authored by Daniel R. Getts

Since Specialization
Citations

This map shows the geographic impact of Daniel R. Getts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Getts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Getts more than expected).

Fields of papers citing papers by Daniel R. Getts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Getts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Getts. The network helps show where Daniel R. Getts may publish in the future.

Co-authorship network of co-authors of Daniel R. Getts

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Getts. A scholar is included among the top collaborators of Daniel R. Getts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Getts. Daniel R. Getts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Ruei‐Zeng, et al.. (2025). CRISPR-Enabled Autonomous Transposable Element (CREATE) for RNA-based gene editing and delivery. EMBO Reports. 26(4). 1062–1083. 2 indexed citations
2.
Lemech, Charlotte, Rasha Cosman, Ganessan Kichenadasse, et al.. (2025). First-in-human mRNA CAR therapy: Correlative biomarker analysis from the MT-302 phase 1 study targeting TROP2 in patients with advanced epithelial tumors.. Journal of Clinical Oncology. 43(16_suppl). 2591–2591. 1 indexed citations
3.
Wang, Yuxiao, Hongyun Zhao, Neha Diwanji, et al.. (2024). In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models. Frontiers in Immunology. 15. 1501365–1501365. 6 indexed citations
4.
Wang, Yuxiao, Michele Gerber, Josephine D’Alessandro, et al.. (2024). Abstract 3612: Preclinical & clinical activity of autologous mRNA engineered chimeric antigen receptor monocytes for targeted cancer immunotherapy. Cancer Research. 84(6_Supplement). 3612–3612. 1 indexed citations
5.
Diwanji, Neha, Daniel R. Getts, & Yuxiao Wang. (2024). Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells. ImmunoHorizons. 8(1). 97–105. 5 indexed citations
6.
Prod’homme, Thomas, Yuxiao Wang, Kyong-Rim Kieffer-Kwon, et al.. (2023). Abstract CT131: Initial preclinical and clinical experience of autologous engineered monocytes in T cell lymphoma patients. Cancer Research. 83(8_Supplement). CT131–CT131. 2 indexed citations
7.
Freitag, Tobias, Joseph R. Podojil, Ryan M. Pearson, et al.. (2020). Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease. Gastroenterology. 158(6). 1667–1681.e12. 100 indexed citations
8.
Zimmermann, Julian, Marius Krauthausen, Markus J. Hofer, et al.. (2019). CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model. Molecular Neurobiology. 56(12). 7977–7993. 14 indexed citations
9.
Pearson, Ryan M., Liam M. Casey, Kevin R. Hughes, et al.. (2017). Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates. Molecular Therapy. 25(7). 1655–1664. 77 indexed citations
10.
Prasad, Suchitra, Tobias Neef, Dan Xu, et al.. (2017). Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells. Journal of Autoimmunity. 89. 112–124. 84 indexed citations
11.
Terry, Rachael, Céline Deffrasnes, Daniel R. Getts, et al.. (2014). Defective Inflammatory Monocyte Development in IRF8-Deficient Mice Abrogates Migration to the West Nile Virus-Infected Brain. Journal of Innate Immunity. 7(1). 102–112. 19 indexed citations
12.
Ashhurst, Thomas M., Caryn van Vreden, Luis Munoz‐Erazo, et al.. (2013). Antiviral macrophage responses in flavivirus encephalitis.. Europe PMC (PubMed Central). 138(5). 632–47. 22 indexed citations
13.
Martin, Aaron J., Roland Tisch, & Daniel R. Getts. (2013). Manipulating T cell-mediated pathology: Targets and functions of monoclonal antibody immunotherapy. Clinical Immunology. 148(1). 136–147. 12 indexed citations
14.
Terry, Rachael, Daniel R. Getts, Céline Deffrasnes, et al.. (2012). Inflammatory monocytes and the pathogenesis of viral encephalitis. Journal of Neuroinflammation. 9(1). 270–270. 110 indexed citations
15.
Getts, Daniel R., Rachael Terry, Meghann Teague Getts, et al.. (2012). Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. Journal of Neuroinflammation. 9(1). 246–246. 60 indexed citations
16.
Getts, Daniel R., Aaron J. Martin, Derrick McCarthy, et al.. (2012). Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nature Biotechnology. 30(12). 1217–1224. 317 indexed citations
17.
Getts, Daniel R., Rachael Terry, Meghann Teague Getts, et al.. (2008). Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. The Journal of Experimental Medicine. 205(10). 2319–2337. 271 indexed citations
18.
Getts, Meghann Teague, Daniel R. Getts, Adam P. Kohm, & Stephen D. Miller. (2008). Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis. Therapy. 5(5). 631–640. 16 indexed citations
19.
Müller, Marcus, Sally L. Carter, Markus J. Hofer, et al.. (2007). CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System. The Journal of Immunology. 179(5). 2774–2786. 168 indexed citations
20.
Getts, Daniel R., Izuru Matsumoto, Marcus Müller, et al.. (2007). Role of IFN‐γ in an experimental murine model of West Nile virus‐induced seizures. Journal of Neurochemistry. 103(3). 1019–1030. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026